Clinical Study

A151216- Adjuvant Lung Cancer Enrichment Marker Identification And Sequencing Trial (Alchemist)

Posted Date: May 15, 2019

  • Investigator: John Morris
  • Specialties: Cancer, Lung Cancer, Oncology
  • Type of Study: Drug

The purpose of this research study is to examine lung cancer patients, surgically removed tumors for certain genetic changes, and to possibly refer these patients to a treatment study with drugs that may specifically target tumors that have these genetic changes.

Criteria:

To Be Eligible: Must Have Lung Cancer Tumor Which Has Already Been Surgically Removed, Age 18 Or Older, No Prior Advanced/Metastatic Cancer Within 5 Years, Nonpregnant/Breastfeeding

Keywords:

Cancer, Lung, Surgery, A151216, Marker

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.